Phreesia, INC Form 4 insider transactions

NYSE
Phreesia's Principal Accounting Officer, Yvonne Hui, sold 582 shares of common stock for $28 per share on June 10, 2025, as part of a pre-arranged 10b5-1 trading plan.
NYSE
Yvonne Hui, Principal Accounting Officer of Phreesia Inc., reports the acquisition of 9,000 shares of common stock and disposal of shares on May 15, 2025, along with holding 31,592 shares following the transaction.
NYSE
David Linetsky, SVP of Life Sciences at Phreesia, Inc., files a Form 4 to correct previously unreported transactions and adjustments to the beneficial ownership of common stock held by his spouse.
NYSE
Director Gillian Munson acquired 400 shares of Phreesia Inc. common stock at $24.96 per share on April 30, 2025, through deferred stock units.
NYSE
Director Lainie Goldstein acquired 400 shares of Phreesia, Inc. common stock at $24.96 per share on April 30, 2025, through the receipt of deferred stock units (DSUs) in lieu of an annual cash retainer.
NYSE
Director Edward Cahill acquired 400 shares of Phreesia, Inc. common stock at $24.96 per share on April 30, 2025, through deferred stock units (DSUs) in lieu of an annual cash retainer.
NYSE
David Linetsky, SVP of Life Sciences at Phreesia, Inc., reported the sale of 260 shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
Yvonne Hui, Principal Accounting Officer of Phreesia Inc., reports the sale of company stock to cover tax obligations and pursuant to a pre-arranged trading plan.
NYSE
David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold shares of common stock to cover tax obligations and pursuant to a pre-arranged Rule 10b5-1 trading plan.
NYSE
Amy Beth VanDuyn, SVP of Human Resources at Phreesia Inc., sold 624 shares of common stock on April 16, 2025, to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
Chief Operating Officer of Phreesia Inc., Evan Roberts, disposed of 1,845 shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
Chaim Indig, CEO of Phreesia, Inc., sold shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
Yvonne Hui, Principal Accounting Officer of Phreesia Inc., reported the sale of company stock on April 15 and 16, 2025, according to a Form 4 filing with the SEC.
NYSE
Allison C. Hoffman, General Counsel & Secretary of Phreesia Inc., reports the sale of 1,213 shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
Balaji Gandhi, CFO of Phreesia, Inc., sold 864 shares of common stock on April 16, 2025, to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
Phreesia's CEO, Chaim Indig, disposed of shares to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
Amy Beth VanDuyn, SVP of Human Resources at Phreesia Inc., sold shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
Evan Roberts, Chief Operating Officer of Phreesia Inc., sold shares of common stock on April 8, 2025, to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
Yvonne Hui, Principal Accounting Officer of Phreesia Inc., sold shares of common stock to cover tax obligations and under a pre-arranged 10b5-1 trading plan.
NYSE
Allison C. Hoffman, General Counsel & Secretary of Phreesia Inc., sold shares of common stock to cover tax obligations and under a pre-arranged 10b5-1 trading plan.
NYSE
Balaji Gandhi, CFO of Phreesia, Inc., sold shares of common stock on April 8, 2025, to cover tax withholding obligations related to the settlement of restricted stock units.
NYSE
Balaji Gandhi, CFO of Phreesia, Inc., reports acquiring 12,865 shares of common stock on April 4, 2025, bringing his total holdings to 116,456 shares.
NYSE
Allison C. Hoffman, General Counsel & Secretary of Phreesia Inc., reports acquiring 10,720 shares of common stock on April 4, 2025, through the conversion of a cash bonus into Restricted Stock Units (RSUs).
NYSE
Yvonne Hui, Principal Accounting Officer of Phreesia Inc., reports the acquisition of 4,680 Restricted Stock Units (RSUs) in lieu of a cash bonus, fully vested as of the grant date.
NYSE
Amy Beth VanDuyn, SVP of Human Resources at Phreesia, Inc., reports the acquisition of 3,752 Restricted Stock Units (RSUs) in lieu of a portion of her cash bonus.
NYSE
Phreesia's CEO, Chaim Indig, acquired shares in lieu of a cash bonus and corrected a previous overstatement of holdings.
NYSE
Evan Roberts, Chief Operating Officer of Phreesia Inc., reports acquiring 12,865 shares of common stock through Restricted Stock Units (RSUs) in lieu of a cash bonus.
NYSE
David Linetsky, SVP of Life Sciences at Phreesia, Inc., filed a Form 4 detailing a corrected stock holding and a grant of Restricted Stock Units (RSUs) in lieu of a portion of his cash bonus.
NYSE
Edward Cahill, a director at Phreesia, Inc., filed an amended Form 4 to correct the reported amount of securities beneficially owned, including previously omitted restricted stock units.